Stay Informed

News

All News Announcements Blog GHTC in the Media Advocacy Actions
GHTC delivers statement on Nagoya Protocol at WHO Executive Board Meeting
PATH/Matthew Dakin
February 7, 2020

GHTC delivers statement on Nagoya Protocol at WHO Executive Board Meeting

GHTC delivered a statement at the 146th session of the World Health Organization (WHO) Executive Board calling on WHO to continue assessing the impact of the Nagoya Protocol and national implementing legislation on public health. The statement, issued through the Global Health Council, encourages WHO to conduct a review of all existing legislation and provisions governing international sample and pathogen sharing to present a fuller picture of potential impact.

Learn More
GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board Meeting
PATH/Eric Becker
February 5, 2020

GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board Meeting

GHTC delivered a statement at the 146th session of the World Health Organization (WHO) Executive Board welcoming WHO efforts to address barriers to access to quality, affordable health products and urging the expansion of the essential diagnostics list as part of these efforts. The statement, issued through the Global Health Council, also encourages WHO and member states to support regulatory capacity strengthening and to better leverage the expertise of product development partnerships.

Learn More
GHTC delivers statement on NTDs at WHO Executive Board Meeting
PATH/Georgina Goodwin
February 5, 2020

GHTC delivers statement on NTDs at WHO Executive Board Meeting

GHTC delivered a statement at the 146th session of the World Health Organization (WHO) Executive Board calling on WHO and member states to support R&D of new vaccines, drugs, diagnostics to combat neglected tropical diseases (NTDs), noting the significant prevention and treatment gaps that remain. The statement, issued through the Global Health Council, also asks WHO to support the official adoption of World NTD Day to continue to raise awareness of these historically neglected diseases.

Learn More
GHTC issues statement on ending tuberculosis at WHO Executive Board Meeting
PATH/Matthew Dakin
February 4, 2020

GHTC issues statement on ending tuberculosis at WHO Executive Board Meeting

GHTC issued a statement at the 146th session of the World Health Organization (WHO) Executive Board calling for member states to close the US$1.3 billion annual funding gap for tuberculosis R&D. The statement, issued through the Global Health Council in partnership with the Infectious Diseases Society of America, highlights the range of solutions urgently needed to stem the epidemic including new drugs, preventative therapies, vaccines, and diagnostics, including rapid molecular and point of care tools.

Learn More
GHTC issues statement on global vaccine action plan at WHO Executive Board Meeting
PATH/Matthew Dakin
February 4, 2020

GHTC issues statement on global vaccine action plan at WHO Executive Board Meeting

GHTC issued a statement at the 146th session of the World Health Organization (WHO) Executive Board applauding WHO and member states on achieving progress on global immunization targets and calling for greater investment in R&D for new vaccine technologies. The statement was issued through the Global Health Council in partnership with the Infectious Diseases Society of America.

Learn More
GHTC joins sign-on letter urging passage of FY20 Defense appropriations bill to protect funding for Defense Health Research Programs
PATH/Patrick McKern
December 5, 2019

GHTC joins sign-on letter urging passage of FY20 Defense appropriations bill to protect funding for Defense Health Research Programs

GHTC joined 103 organizations in endorsing a letter to House and Senate leadership urging them to complete final negotiations on the fiscal year (FY) 2020 Defense Appropriations Act and pass the bill in order to protect funding for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs—which have historically supported research on global health issues like malaria and tuberculosis.

PDF